Abstract
Aims
Fabry disease (FD) is a rare X-linked genetic disorder caused by the deficiency or absent activity of lysosomal α-galactosidase A. Cardiovascular remodelling is a hallmark of FD. The present study aimed to comprehensively evaluate the cardiac, vascular and microvascular status in a population of patients with genetic mutations for FD without left ventricular hypertrophy (LVH).
Methods and results
This study includes subjects carrying genetic mutations for FD (Fabry disease mutation-carrier, FDMC) without LVH (n = 19). A group of control subjects (n = 19) matched for age, sex, body mass index and cardiovascular risk factors were also included. All subjects underwent echocardiography, carotid ultrasound scan, endothelial flow-mediated dilatation (FMD) and nailfold capillaroscopy (NFC) assessment. When compared to the subjects in the control group, FDMC patients showed significantly lower mean values of systolic myocardial velocity (7.33 ± 1.28 vs. 10.08 ± 1.63 cm/s, p < 0.0001), longitudinal systolic strain (−18.07 ± 1.72 vs. −21.15 ± 2.22 %, p < 0.0001), significantly higher E/E’ mean values (7.15 ± 1.54 vs. 5.98 ± 1.27, p = 0.016) and intima-media thickness mean values (0.80 ± 0.20 vs. 0.61 ± 0.19 mm, p = 0.005), significantly lower FMD (8.3 ± 4.6 vs. 12.2 ± 5.0 %, p = 0.02), more atypical capillaries and irregular NFC architecture in FDMC than control subjects (52.6 vs. 0 %, p < 0.0001; 78.9 vs. 36.8 %, p = 0.02 respectively).
Conclusions
FD progressively involves cardiac, macrovascular and microvascular systems in an early stage. These features are present even in asymptomatic mutation carriers without LVH.
Similar content being viewed by others
References
Altarescu G, Moore DF, Pursley R et al (2001) Enhanced endothelium-dependent vasodilation in Fabry disease. Stroke 32:1559–1562
Barbey F, Brakch N, Linhart A et al (2006a) Cardiac and vascular hypertrophy in Fabry disease: evidence for a new mechanism independent of blood pressure and glycosphingolipid deposition. Arterioscler Thromb Vasc Biol 26:839–844
Barbey F, Brakch N, Linhart A et al (2006b) Increased carotid intima-media thickness in the absence of atherosclerotic plaques in an adult population with Fabry disease. Acta Paediatr Suppl 95:63–68
Bollinger A, Fagrell B (1990) Clinical capillaroscopy. A guide to its use in clinical research and practice, Toronto. Hogrete & Huber, Toronto, pp 1–158
Boutouyrie P, Laurent S, Laloux B, Lidove O, Grunfeld JP, Germain DP (2002) Arterial remodelling in Fabry disease. Acta Paediatr 91(suppl 439):62–66
Chimenti C, Hamdani N, Boontje NM et al (2008) Myofilament degradation and dysfunction of human cardiomyocytes in Fabry disease. Am J Pathol 172:1482–1490
Corretti MC, Anderson TJ, Benjamin EJ, International Brachial Artery Reactivity Task Force et al (2002) Guidelines for the ultrasound assessment of endothelial-dependent flow-mediated vasodilation of the brachial artery: a report of the International Brachial Artery Reactivity Task Force. J Am Coll Cardiol 39:257–265
Desnick RJ, Blieden LC, Sharp HL, Hofschire PJ, Moller JH (1976) Cardiac valvular anomalies in Fabry disease. Clinical, morphologic, and biochemical studies. Circulation 54:818–825
Devereux RB, Reicheck N (1997) Echocardiographic determination of left ventricular mass in man: anatomic validation of the method. Circulation 55:613–619
Dütsch M, Marthol H, Stemper B, Brys M, Haendl T, Hilz MJ (2002) Small fiber dysfunction predominates in Fabry neuropathy. J Clin Neurophysiol 19:575–586
Furchgott RF, Zawadzki JV (1980) The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine. Nature 288:373–376
Galderisi M, Henein MY, D’hooge J, European Association of Echocardiography et al (2011) Recommendations of the European Association of Echocardiography: how to use echo-Doppler in clinical trials: different modalities for different purposes. Eur J Echocardiogr 12:339–353
Germain DP (2010) Fabry disease. Orphanet J Rare Dis 5:30
Kalliokoski RJ, Kalliokoski KK, Penttinen M et al (2006) Structural and functional changes in peripheral vasculature of Fabry patients. J Inherit Metab Dis 29:660–666
Lakoumentas JA, Panou FK, Kotseroglou VK, Aggeli KI, Harbis PK (2005) The Tei index of myocardial performance: applications in cardiology. Hellenic J Cardiol 46:52–58
Linhart A, Palecek T, Bultas J et al (2000) New insights in cardiac structural changes in patients with Fabry’s disease. Am Heart J 139:1101–1108
Linthorst GE, Poorthuis BJ, Hollak CE (2008) Enzyme activity for determination of presence of Fabry disease in women results in 40% false-negative results. J Am Coll Cardiol 51:2082–2083
Lonzetti LS, Joyal F, Raynauld JP et al (2001) Updating the American College of Rheumatology preliminary classification criteria for systemic sclerosis: addition of severe nailfold capillaroscopy abnormalities markedly increases the sensitivity for limited scleroderma. Arthritis Rheum 44:735–736
Maier EM, Osterrieder S, Whybra C et al (2006) Disease manifestations and x inactivation in heterozygous females with Fabry disease. Acta Paediatr 95:30–38
Nagueh SF, Middleton KJ, Kopelen HA, Zoghbi WA, Quiñones MA (1997) Doppler tissue imaging: a noninvasive technique for evaluation of left ventricular relaxation and estimation of filling pressures. J Am Coll Cardiol 30:1527–1533
Nagueh SF, Appleton CP, Gillebert TC et al (2009) Recommendations for the evaluation of left ventricular diastolic function by echocardiography. Eur J Echocardiogr 10:165–193
Pieroni M, Chimenti C, Ricci R, Sale P, Russo MA, Frustaci A (2003) Early detection of Fabry cardiomyopathy by tissue Doppler imaging. Circulation 107:1978–1984
Puccio D, Coppola G, Corrado E et al (2005) Non invasive evaluation of endothelial function in patients with Anderson-Fabry disease. Int Angiol 24:295–299
Seino Y, Vyden JK, Philipart M, Rose HB, Nagasawa K (1983) Peripheral hemodynamics in patients with Fabry’s disease. Am Heart J 105:783–787
Stein JH, Korcarz CE, Hurst RT, American Society of Echocardiography Carotid Intima-Media Thickness Task Force et al (2008) Use of carotid ultrasound to identify subclinical vascular disease and evaluate cardiovascular disease risk: a consensus statement from the American Society of Echocardiography Carotid Intima-Media Thickness Task Force. Endorsed by the Society for Vascular Medicine. J Am Soc Echocardiogr 21:93–111
Stemper B, Hilz MJ (2003) Postischemic cutaneous hyperperfusion in the presence of forearm hypoperfusion suggests sympathetic vasomotor dysfunction in Fabry disease. J Neurol 250:970–976
Toro R, Perez-Isla L, Doxastaquis G et al (2009) Clinical usefulness of tissue Doppler imaging in predicting preclinical Fabry cardiomyopathy. Int J Cardiol 32:38–44
Wasik JS, Simon RW, Meier T, Steinmann B, Amann-Vesti BR (2009) Nailfold capillaroscopy: specific features in Fabry disease. Clin Hemorheol Microcirc 42:99–106
Zamorano J, Serra V, Pérez de Isla L et al (2011) Usefulness of tissue Doppler on early detection of cardiac disease in Fabry patients and potential role of enzyme replacement therapy (ERT) for avoiding progression of disease. Eur J Echocardiogr 12:671–677
Acknowledgements
The authors express their gratitude to Caren Conticello for her assistance in revision of the English text.
Funding sources
No extramural funding was used to support this work.
Conflict of interest
None.
Author information
Authors and Affiliations
Corresponding author
Additional information
Communicated by: Ed Wraith
Rights and permissions
About this article
Cite this article
Costanzo, L., Buccheri, S., Capranzano, P. et al. Early cardiovascular remodelling in Fabry disease. J Inherit Metab Dis 37, 109–116 (2014). https://doi.org/10.1007/s10545-013-9607-1
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10545-013-9607-1